Cheng Sohanya Roshan's most recent trade in Karyopharm Therapeutics Inc was a trade of 3,445 Common Stock done at an average price of $6.3 . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 04 Mar 2025 | 3,445 | 34,314 (0%) | 0% | 6.3 | 21,669 | Common Stock |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 10,833 | 10,833 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 9,166 | 9,166 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 5,416 | 33,176 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 4,583 | 37,759 (0%) | 0% | 0 | Common Stock | |
| Carisma Therapeutics Inc | Sohanya Roshan Cheng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2024 | 38,700 | 38,700 | - | - | Stock Option (Right to Buy) | |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 04 Sep 2024 | 5,356 | 404,051 (0%) | 0% | 0.7 | 3,866 | Common Stock |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 29 Feb 2024 | 21,840 | 398,618 (0%) | 0% | 1.2 | 25,553 | Common |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 29 Feb 2024 | 5,109 | 393,509 (0%) | 0% | 1.2 | 6,131 | Common |
| Karyopharm Therapeutics Inc | Roshan Cheng Sohanya | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 198,959 | 420,458 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 14,167 | 221,499 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 08 Jun 2023 | 1,839 | 211,501 (0%) | 0% | 2.4 | 4,322 | Common Stock |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 100,000 | 221,926 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 3.03 per share. | 28 Feb 2023 | 11,239 | 210,687 (0%) | 0% | 3.0 | 34,045 | Common Stock |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 30,000 | 119,949 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.20 per share. | 13 Jun 2022 | 1,485 | 89,949 (0%) | 0% | 5.2 | 7,722 | Common Stock |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.35 per share. | 13 Jun 2022 | 66 | 91,434 (0%) | 0% | 5.3 | 353 | Common Stock |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 108,000 | 108,000 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 84,000 | 91,500 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | SVP Sales & Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 125,000 | 125,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | SVP Sales & Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 7,500 | 7,500 (0%) | 0% | 0 | Common Stock |